Lamivudine Resistance in Human T-Cell Leukemia Virus Type 1 May Be Due to a Polymorphism at Codon 118 (V→I) of the Reverse Transcriptase
Authors:
Open Access
- 1 May 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (5) , 1774-1775
Abstract
In a recent report, Balestrieri et al. ([1][1]) asserted that the effect of lamivudine (3TC) against human T-cell leukemia virus type 1 (HTLV-1) at therapeutic concentrations is seen mainly on cell proliferation, with little or no direct antiviral effect. These findings are supported by biochemicalKeywords
This publication has 9 references indexed in Scilit:
- Effect of Lamivudine on Transmission of Human T-Cell Lymphotropic Virus Type 1 to Adult Peripheral Blood Mononuclear Cells In VitroAntimicrobial Agents and Chemotherapy, 2002
- Mechanisms of resistance to antiretroviral drugs--clinical implications.2002
- The effect of antiretroviral therapy on HTLV infectionVirus Research, 2001
- Susceptibility of Human T Cell Leukemia Virus Type 1 to Reverse‐Transcriptase Inhibitors: Evidence for Resistance to LamivudineThe Journal of Infectious Diseases, 2001
- Susceptibility of the Porcine Endogenous Retrovirus to Reverse Transcriptase and Protease InhibitorsJournal of Virology, 2001
- Wild-Type and YMDD Mutant Murine Leukemia Virus Reverse Transcriptases Are Resistant to 2′,3′-Dideoxy-3′-ThiacytidineJournal of Virology, 2000
- In Vivo Fluctuation of HTLV-I and HTLV-II Proviral Load in Patients Receiving Antiretroviral DrugsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184VAntimicrobial Agents and Chemotherapy, 2000
- Effect of Lamivudine on Human T-Cell Leukemia Virus Type 1 (HTLV-1) DNA Copy Number, T-Cell Phenotype, and Anti-Tax Cytotoxic T-Cell Frequency in Patients with HTLV-1-Associated MyelopathyJournal of Virology, 1999